Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 1
1969 2
1970 2
1971 1
1974 2
1975 1
1976 2
1977 3
1978 2
1979 5
1980 2
1981 8
1982 4
1983 6
1984 7
1985 9
1986 6
1987 4
1988 8
1989 8
1990 7
1991 10
1992 6
1993 4
1994 7
1995 4
1996 4
1997 9
1998 5
1999 8
2000 7
2001 13
2002 5
2003 13
2004 19
2005 26
2006 15
2007 17
2008 23
2009 12
2010 19
2011 20
2012 19
2013 20
2014 26
2015 22
2016 22
2017 20
2018 20
2019 26
2020 30
2021 36
2022 43
2023 32
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

612 results

Results by year

Filters applied: . Clear all
Page 1
Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patients.
Pan Y, Zhang JT, Gao X, Chen ZY, Yan B, Tan PX, Yang XR, Gao W, Gong Y, Tian Z, Liu SM, Lin H, Sun H, Huang J, Liu SY, Yan HH, Dong S, Xu CR, Chen HJ, Wang Z, Li P, Guan Y, Wang BC, Yang JJ, Tu HY, Yang XN, Zhong WZ, Xia X, Yi X, Zhou Q, Wu YL. Pan Y, et al. Among authors: wang bc. Cancer Cell. 2023 Oct 9;41(10):1763-1773.e4. doi: 10.1016/j.ccell.2023.09.007. Cancer Cell. 2023. PMID: 37816331
First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial.
Liu SM, Tu HY, Wei XW, Yan HH, Dong XR, Cui JW, Zhou Z, Xu CR, Zheng MY, Li YS, Wang Z, Bai XY, Li AN, Sun YL, Huang J, Lin JX, Ke EE, Xu BF, Lu C, Du Y, Chen Y, Ma R, Wang BH, Cang SD, Wang BC, Chen HJ, Yang JJ, Li Y, Zhou Q, Wu YL. Liu SM, et al. Among authors: wang bc. Nat Med. 2023 Aug;29(8):2079-2086. doi: 10.1038/s41591-023-02461-x. Epub 2023 Jul 24. Nat Med. 2023. PMID: 37488286 Clinical Trial.
Native SAD is maturing.
Rose JP, Wang BC, Weiss MS. Rose JP, et al. Among authors: wang bc. IUCrJ. 2015 May 14;2(Pt 4):431-40. doi: 10.1107/S2052252515008337. eCollection 2015 Jul 1. IUCrJ. 2015. PMID: 26175902 Free PMC article. Review.
Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study.
Liu SY, Dong S, Yang XN, Liao RQ, Jiang BY, Wang Q, Ben XS, Qiao GB, Lin JT, Yan HH, Yan LX, Nie Q, Tu HY, Wang BC, Yang JJ, Zhou Q, Li HR, Liu K, Wu W, Liu SM, Zhong WZ, Wu YL. Liu SY, et al. Among authors: wang bc. Signal Transduct Target Ther. 2023 Dec 6;8(1):442. doi: 10.1038/s41392-023-01700-4. Signal Transduct Target Ther. 2023. PMID: 38057314 Free PMC article. Clinical Trial.
Role of MicroRNAs in Malignant Glioma.
Wang BC, Ma J. Wang BC, et al. Chin Med J (Engl). 2015 May 5;128(9):1238-44. doi: 10.4103/0366-6999.156141. Chin Med J (Engl). 2015. PMID: 25947409 Free PMC article. Review.
UHRF1 Induces Metastasis in Thyroid Cancer.
Kuang BH, Lin GH, Liu Q, Wang BC. Kuang BH, et al. Among authors: wang bc. J Oncol. 2022 Aug 13;2022:7716427. doi: 10.1155/2022/7716427. eCollection 2022. J Oncol. 2022. PMID: 35996525 Free PMC article.
612 results